---
category: news
title: "Lex Lands $2.75M For AI Writing Tools"
excerpt: "Los Angeles-based Lex, a startup developing AI-powered writing tools, announced this morning that it has raised $2.75M in a seed funding round. The funding was led by True Ventures. According to the company,"
publishedDateTime: 2023-08-23T18:06:00Z
originalUrl: "https://www.socaltech.com/lex_lands___7_m_for_ai_writing_tools/s-0083597.html"
webUrl: "https://www.socaltech.com/lex_lands___7_m_for_ai_writing_tools/s-0083597.html"
type: article
quality: 17
heat: -1
published: false

provider:
  name: Incubators
  domain: socaltech.com

topics:
  - AI

related:
  - title: "Genesis raises $200m for AI drug discovery engine"
    excerpt: "The latest round takes the total raised by Burlingame, California-based Genesis to $280 million and will be used to transition to a clinical-stage drug developer, according to the company. Its first round brought in $52 million in 2020."
    publishedDateTime: 2023-08-21T21:19:00Z
    webUrl: "https://pharmaphorum.com/news/genesis-raises-200m-ai-drug-discovery-engine"
    type: article
    provider:
      name: pharmaphorum
      domain: pharmaphorum.com
    quality: 39
    images:
      - url: "https://pharmaphorum.com/sites/default/files/2023-08/DNA_molecules_internal_organs.jpg"
        width: 900
        height: 600
        isCached: true
  - title: "Genesis Therapeutics Rakes In $200M For AI-Powered Drug Discovery"
    excerpt: "The startup’s physics-centric AI platform is what sets it apart from its competitors, Sklaroff argued. Genesis has “deep expertise” in physics-based methods for computational chemistry, which the company combines with its proprietary machine learning ..."
    publishedDateTime: 2023-08-22T00:11:00Z
    webUrl: "https://medcitynews.com/2023/08/biotech-ai-physics-drug-discovery-venture-capital/"
    type: article
    provider:
      name: MedCity News
      domain: medcitynews.com
    quality: 37
    images:
      - url: "https://medcitynews.com/uploads/2017/01/GettyImages-488634096.jpg"
        width: 683
        height: 512
        isCached: true
  - title: "AI drug discovery company Genesis Therapeutics scores $200 million in new funding"
    excerpt: "A Stanford University spinout, promising a new era of AI-guided drug discovery ... Genesis has no clinical data – in fact, it’s not officially saying yet when it will even start clinical trials, let alone which conditions it is targeting – but ..."
    publishedDateTime: 2023-08-22T15:21:00Z
    webUrl: "https://www.bizjournals.com/sanfrancisco/news/2023/08/22/genesis-therapeutics-200-million-funding.html"
    type: article
    provider:
      name: The Business Journals
      domain: bizjournals.com
    quality: 12

secured: "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;7W2SXPvG8zbFr91V9buqbQ=="
---

